# Efficacy Study for Standard Versus Double Dose of Amoxicillin in WHO Defined Non-severe Pneumonia

> **NCT01375426** · PHASE1,PHASE2 · COMPLETED · sponsor: **ARI Research Cell** · enrollment: 900 (—)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** Oral amoxicillin

## Key facts

- **NCT ID:** NCT01375426
- **Lead sponsor:** ARI Research Cell
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2004-06
- **Target enrollment:** 900 (—)
- **Last updated:** 2011-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01375426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01375426, "Efficacy Study for Standard Versus Double Dose of Amoxicillin in WHO Defined Non-severe Pneumonia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01375426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*